Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
X-ray crystallography studies, as well as live-cell fluorescent imaging, have recently challenged the traditional view of protein kinase CK2. Unbalanced expression of catalytic and regulatory CK2 subunits has been observed in a variety of tissues and tumours. Thus the potential intersubunit flexibility suggested by these studies raises the likely prospect that the CK2 holoenzyme complex is subject to disassembly and reassembly. In the present paper, we show evidence for the reversible multimeric organization of the CK2 holoenzyme complex in vitro. We used a combination of site-directed mutagenesis, binding experiments and functional assays to show that, both in vitro and in vivo, only a small set of primary hydrophobic residues of CK2beta which contacts at the centre of the CK2alpha/CK2beta interface dominates affinity. The results indicate that a double mutation in CK2beta of amino acids Tyr188 and Phe190, which are complementary and fill up a hydrophobic pocket of CK2alpha, is the most disruptive to CK2alpha binding both in vitro and in living cells. Further characterization of hotspots in a cluster of hydrophobic amino acids centred around Tyr188-Phe190 led us to the structure-based design of small-peptide inhibitors. One conformationally constrained 11-mer peptide (Pc) represents a unique CK2beta-based small molecule that was particularly efficient (i) to antagonize the interaction between the CK2 subunits, (ii) to inhibit the assembly of the CK2 holoenzyme complex, and (iii) to strongly affect its substrate preference.
Laudet
Béatrice
B
Inserm, U873, Grenoble, F-38054, France.
Barette
Caroline
C
Dulery
Vincent
V
Renaudet
Olivier
O
Dumy
Pascal
P
Metz
Alexandra
A
Prudent
Renaud
R
Deshiere
Alexandre
A
Dideberg
Otto
O
Filhol
Odile
O
Cochet
Claude
C
D000595:Amino Acid Sequence; D001483:Base Sequence; D047390:Casein Kinase II / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D002384:Catalysis; D018360:Crystallography, X-Ray; D017931:DNA Primers; D006367:HeLa Cells; D006801:Humans; D008024:Ligands; D016297:Mutagenesis, Site-Directed; D010455:Peptides / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D011487:Protein Conformation; D047428:Protein Kinase Inhibitors / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*; D011994:Recombinant Proteins / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D013329:Structure-Activity Relationship; D020349:Surface Plasmon Resonance
D017931:DNA Primers; D008024:Ligands; D010455:Peptides; D047428:Protein Kinase Inhibitors; D011994:Recombinant Proteins; D047390:Casein Kinase II
Nat Biotechnol. 2003 May;21(5):539-45
12692560
Oncogene. 2006 Nov 30;25(56):7343-53
16751801
J Cell Sci. 2002 Oct 15;115(Pt 20):3873-8
12244125
Science. 1997 May 9;276(5314):952-5
9139659
Eur J Biochem. 1991 May 23;198(1):25-30
2040287
Ann N Y Acad Sci. 2002 Nov;973:272-7
12485876
Nature. 1998 Sep 17;395(6699):297-300
9751060
FASEB J. 1995 Mar;9(5):313-23
7896000
Bioessays. 1995 Jun;17(6):471-80
7575488
Mol Cell Biol. 2003 Feb;23(3):975-87
12529402
EMBO Rep. 2004 Apr;5(4):351-5
15060571
Biochem J. 2003 Jan 1;369(Pt 1):1-15
12396231
DNA Repair (Amst). 2002 Mar 28;1(3):225-35
12509254
Oncogene. 2003 Jan 16;22(2):220-32
12527891
EMBO J. 1999 Jun 1;18(11):2930-40
10357806
Biochemistry. 1991 Nov 19;30(46):11133-40
1932033
J Comput Chem. 2004 Oct;25(13):1605-12
15264254
J Cell Biochem Suppl. 1998;30-31:129-36
9893264
FEBS Lett. 1999 Dec 3;462(3):353-7
10622724
Mol Cell Biochem. 2005 Jun;274(1-2):15-22
16335524
Org Lett. 2003 Feb 6;5(3):243-6
12556162
Int J Biol Sci. 2005;1(2):67-79
15951851
Angew Chem Int Ed Engl. 2003 Jun 6;42(22):2462-81
12800163
ChemMedChem. 2006 Apr;1(4):400-11
16892375
Nat Rev Mol Cell Biol. 2006 Jun;7(6):449-56
16625152
Biochem J. 2001 Aug 15;358(Pt 1):87-94
11485555
J Biol Chem. 1996 Jul 26;271(30):17798-803
8663446
J Biol Chem. 1997 Dec 19;272(51):31998-2005
9405392
EMBO J. 2001 Oct 1;20(19):5320-31
11574463
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2184-95
15572771
Mol Cell Biol. 2006 Apr;26(8):3008-17
16581776
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
15299374
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11273-8
13679575
Eur J Biochem. 1986 Jul 1;158(1):99-106
3089780
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
Biochemistry. 1997 Jun 10;36(23):7192-8
9188720
Mol Cell Biochem. 2005 Jun;274(1-2):23-9
16335525
J Biol Chem. 1997 Jun 27;272(26):16343-50
9195940
Mol Cell Biochem. 1999 Jan;191(1-2):43-50
10094391
J Mol Biol. 2003 Jul 25;330(5):925-34
12860116
J Biol Chem. 1990 Nov 25;265(33):20609-15
2243106